Vestmark Advisory Solutions Inc. Purchases Shares of 33,360 Henry Schein, Inc. $HSIC

Vestmark Advisory Solutions Inc. acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the second quarter, HoldingsChannel reports. The fund acquired 33,360 shares of the company’s stock, valued at approximately $2,437,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Nisa Investment Advisors LLC grew its holdings in Henry Schein by 5.8% during the first quarter. Nisa Investment Advisors LLC now owns 31,866 shares of the company’s stock worth $2,183,000 after purchasing an additional 1,751 shares during the period. Allworth Financial LP lifted its position in shares of Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company’s stock valued at $78,000 after buying an additional 232 shares during the last quarter. MQS Management LLC bought a new position in shares of Henry Schein during the 1st quarter worth approximately $502,000. Edgestream Partners L.P. boosted its stake in shares of Henry Schein by 218.0% during the 1st quarter. Edgestream Partners L.P. now owns 33,301 shares of the company’s stock worth $2,281,000 after acquiring an additional 22,829 shares during the period. Finally, Dakota Wealth Management increased its holdings in shares of Henry Schein by 34.7% during the 1st quarter. Dakota Wealth Management now owns 17,656 shares of the company’s stock worth $1,209,000 after acquiring an additional 4,551 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HSIC has been the subject of several research reports. JPMorgan Chase & Co. raised their price target on Henry Schein from $76.00 to $78.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Wells Fargo & Company upped their price objective on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a report on Wednesday, November 5th. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research note on Monday, July 14th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Henry Schein in a report on Friday, October 31st. Finally, Robert W. Baird reiterated a “neutral” rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Henry Schein currently has an average rating of “Hold” and a consensus target price of $76.08.

Henry Schein Stock Up 2.6%

HSIC stock opened at $71.90 on Monday. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock has a market capitalization of $8.46 billion, a price-to-earnings ratio of 23.19, a PEG ratio of 2.06 and a beta of 0.84. The business’s fifty day moving average price is $66.30 and its two-hundred day moving average price is $68.76.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.